Your browser doesn't support javascript.
loading
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model.
Wang, Yufei; Buck, Alicia; Grimaud, Marion; Culhane, Aedin C; Kodangattil, Sreekumar; Razimbaud, Cecile; Bonal, Dennis M; Nguyen, Quang-De; Zhu, Zhu; Wei, Kevin; O'Donnell, Madison L; Huang, Ying; Signoretti, Sabina; Choueiri, Toni K; Freeman, Gordon J; Zhu, Quan; Marasco, Wayne A.
Afiliación
  • Wang Y; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Buck A; Harvard Medical School, Boston, MA 02115, USA.
  • Grimaud M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Culhane AC; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Kodangattil S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Razimbaud C; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.
  • Bonal DM; Limerick Digital Cancer Research Center, Health Research Institute, School of Medicine, University of Limerick, Limerick V94 T9PX, Ireland.
  • Nguyen QD; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Zhu Z; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Wei K; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • O'Donnell ML; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Huang Y; Harvard Medical School, Boston, MA 02115, USA.
  • Signoretti S; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Choueiri TK; Harvard Medical School, Boston, MA 02115, USA.
  • Freeman GJ; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Zhu Q; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Marasco WA; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Mol Ther Oncolytics ; 24: 385-399, 2022 Mar 17.
Article en En | MEDLINE | ID: mdl-35118195
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Oncolytics Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos